Viracta Therapeutics, Inc.
Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase…
Biotechnology
US, Cardiff-by-the-Sea [HQ]
Growth Rates · Payout · Yield
Dividends Over Time
Growth Rates · Payout · Yield
Growth Rates
%
YoY
%
3Yr
%
5Yr
%
10Yr
Key Metrics
- -%
TTM Yield
- -
Average Days Gap
Series
% - -
Yield
0.00%
Payout Ratio
History
We could not find any dividend history for Viracta Therapeutics, Inc..